Pregnancy outcomes in partners of male ankylosing spondylitis patients treated with anti-tumour necrosis factor-α biologics: real-life results from a single-centre cross-sectional study
Sign Up to like & getrecommendations! Published in 2020 at "Rheumatology International"
DOI: 10.1007/s00296-020-04518-3
Abstract: Most patients with inflammatory arthritis are at their reproductive ages. Use of anti-tumour necrosis factor alpha (anti-TNF-α) agents, one of the important treatment options for inflammatory arthritis, can cause foetal morbidity and mortality. While most… read more here.
Keywords: outcomes partners; pregnancy; tnf agents; anti tnf ... See more keywords
Preoperative Anti-TNF Agents and Morbidity After Ileocolonic Resections in Crohn’s Disease: Are Biologics the Only Ones to Blame?
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-021-04976-5
Abstract: Dear Editor, We read with great interest the manuscript entitled “The Impact of Preoperative Anti-TNFα Therapy on Postoperative Outcomes Following Ileocolectomy in Crohn’s Disease” by Kulaylat et al., recently published in the Journal of Gastrointestinal… read more here.
Keywords: tnf agents; anti tnf; morbidity; preoperative anti ... See more keywords
B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.
Sign Up to like & getrecommendations! Published in 2018 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2018.04.016
Abstract: PURPOSE The aim of this article was to review published research related to B lymphocytes in rheumatoid arthritis, their role in the pathogenesis of the disease, the effects of tumor necrosis factor (TNF)-α inhibitors on… read more here.
Keywords: tnf agents; lymphocytes rheumatoid; anti tnf; rheumatoid arthritis ... See more keywords
Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the National Medical Association"
DOI: 10.1016/j.jnma.2018.10.003
Abstract: OBJECTIVE The aim of this study was to determine whether there is any association with anti-tumor necrosis factor (TNF) agent administration and development of new-onset inflammatory bowel disease (IBD) in ankylosing spondylitis (AS) patients. METHODS… read more here.
Keywords: risk; tnf agents; tnf; anti tnf ... See more keywords
Management of severe complications in Behçet’s disease with TNF inhibitors
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2017.1328496
Abstract: ABSTRACT Introduction: The efficacy of anti-TNFα agents has been recently evaluated in many studies in Behçet’s disease (BD), particularly in ocular and life-threatening manifestations such as neurological and vascular disease. Areas covered: The following article… read more here.
Keywords: tnf agents; tnf; disease; efficacy ... See more keywords
Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2019.1631798
Abstract: ABSTRACT Background: Biological therapies have a significant economic and clinical burden but, in general, lose their effectiveness over time. This study evaluated the medication persistence and costs associated to use of anti-TNF agents for psoriatic… read more here.
Keywords: tnf agents; anti tnf; persistence; psoriatic arthritis ... See more keywords
Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFα Agents for Ulcerative Colitis.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of clinical gastroenterology"
DOI: 10.1097/mcg.0000000000001733
Abstract: GOALS Characterize and compare the risk of Clostridioides difficile infection (CDI) and cytomegalovirus colitis (CMVC) after initiation of vedolizumab or anti-tumor necrosis factor (TNF)α agents for ulcerative colitis (UC). BACKGROUND Immunosuppression is a risk factor… read more here.
Keywords: anti tnf; tnf agents; vedolizumab anti; risk ... See more keywords
Adherence to subcutaneous anti‐TNFα agents in patients with rheumatoid arthritis is largely influenced by pain and skin sensations at the injection site
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.13803
Abstract: The aims of this prospective study were to determine the dimension of adherence in rheumatoid arthritis (RA) patients receiving subcutaneously administered anti‐tumor necrosis factor‐α (anti‐TNFα) agents and to evaluate the influence of injection site pain… read more here.
Keywords: anti tnf; pain skin; injection site; tnf agents ... See more keywords
OWE-37 CD4 T-cell HLA-U pseudogene at baseline predicts clinical remission to anti-TNF agents in ulcerative colitis
Sign Up to like & getrecommendations! Published in 2019 at "Gut"
DOI: 10.1136/gutjnl-2019-bsgabstracts.127
Abstract: Introduction Anti-tumour necrosis factor (TNF) agents are used to treat UC but response is variable. Apart from concurrent immunomodulatory therapy and there are no clear predictors of efficacy. Analysis of transcriptome from peripheral blood CD4… read more here.
Keywords: response; anti tnf; tnf agents; clinical remission ... See more keywords
Efficacy and Safety of Anti-Tumor Necrosis Factor-Alpha Agents for Patients with Intestinal Behcet’s Disease: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2022.63.2.148
Abstract: Purpose Intestinal Behcet’s disease (BD) is a systemic autoimmune disease for which treatment options are limited. As a prospective therapeutic strategy for intestinal BD, anti-tumor necrosis factor-alpha (anti-TNF-α) agents have received increasing attention. In this… read more here.
Keywords: anti tnf; safety; tnf agents; safety anti ... See more keywords
Methotrexate Enhances Apoptosis of Transmembrane TNF-Expressing Cells Treated With Anti-TNF Agents
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2020.02042
Abstract: Background Concomitant use of methotrexate (MTX) improves the clinical efficacy of anti-TNF agents in the treatment of rheumatoid arthritis (RA). We aimed to clarify the cytotoxic effect of MTX on transmembrane TNF (tmTNF)-expressing cells treated… read more here.
Keywords: tnf agents; tnf; expressing cells; tnf agent ... See more keywords